Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Yahoo Finance · 24 hours ago
Open | 26.33 |
High | 26.97 |
Low | 26.02 |
Mkt Cap | 150.74B |
P/E (TTM) | 71.95 |
Div & Yield | 1.68 & 6.56% |
Prev. Close | 25.62 |
52 Wk. Low | 25.20 |
52 Wk. High | 40.37 |
Related stocks
American multinational pharmaceutical corporation
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 14.25B | 41.30% ▼ |
Net Income | -3.37B | - |
Diluted EPS | 0.10 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | $0.49 | - |
Q4 2023 | -$0.22 | $0.10 |
Q3 2023 | -$0.34 | -$0.17 |
S&P 500^GSPC | 5,021.66-14.03 (-0.28%) |
Dow 30^DJI | 37,897.18+81.26 (+0.21%) |
Nasdaq^IXIC | 15,607.04-50.79 (-0.32%) |
73.56-16.87% | |
55.29-18.34% | |
144.68-8.65% |